Difficulty: Medium
Average Score: 71%
Practice
A woman, 68 years of age, presents with blunted affect; she seems indifferent to her surroundings and says that she has no sense of pleasure in life. She complains that she hears voices and fears that she is about to be killed. She is admitted to the acute psychiatric ward, where she is given an antipsychotic ├óÔé¼ÔÇ£Drug A. After treatment, her hallucinations and paranoia resolve, but she complains that she has a tremor and cannot move about quickly. After a change in her medication to Drug B, all of her symptoms improved. She does not need to have weekly blood tests. Which one of the following pairs most likely corresponds to Drug A and Drug B?
Correct answer
B
Rationale
The correct answer is B) Haloperidol Olanzapine.
Haloperidol is a first-generation antipsychotic known for its effectiveness in treating psychosis but can commonly cause extrapyramidal side effects like tremors. In this case, Drug A is likely Haloperidol, which improved the patient's hallucinations and paranoia but caused tremors. Drug B, Olanzapine, is a second-generation antipsychotic that is effective in treating psychosis without the same risk of extrapyramidal side effects, making it a suitable alternative for this patient.
Option A, Fluphenazine Clozapine, is incorrect because Clozapine is not associated with the extrapyramidal side effects seen in the patient. Option C, Risperidone Sertraline, is incorrect as Sertraline is an antidepressant and not an antipsychotic. Option D, Thioridazine Clozapine, is incorrect because Thioridazine is more commonly associated with cardiac side effects rather than tremors.
Educationally, understanding the differences between first-generation and second-generation antipsychotics is crucial in selecting appropriate treatments for patients while considering side effect profiles. This case highlights the importance of individualized medication selection to balance symptom relief and side effect management in psychiatric care.
Haloperidol is a first-generation antipsychotic known for its effectiveness in treating psychosis but can commonly cause extrapyramidal side effects like tremors. In this case, Drug A is likely Haloperidol, which improved the patient's hallucinations and paranoia but caused tremors. Drug B, Olanzapine, is a second-generation antipsychotic that is effective in treating psychosis without the same risk of extrapyramidal side effects, making it a suitable alternative for this patient.
Option A, Fluphenazine Clozapine, is incorrect because Clozapine is not associated with the extrapyramidal side effects seen in the patient. Option C, Risperidone Sertraline, is incorrect as Sertraline is an antidepressant and not an antipsychotic. Option D, Thioridazine Clozapine, is incorrect because Thioridazine is more commonly associated with cardiac side effects rather than tremors.
Educationally, understanding the differences between first-generation and second-generation antipsychotics is crucial in selecting appropriate treatments for patients while considering side effect profiles. This case highlights the importance of individualized medication selection to balance symptom relief and side effect management in psychiatric care.